These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4823899)

  • 1. The disposition of the antitumor agent, sangivamycin, in mice.
    Hardesty CT; Chaney NA; Waravdekar VS; Mead JA
    Cancer Res; 1974 May; 34(5):1005-9. PubMed ID: 4823899
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological and biochemical effects of pyrazofurin in humans.
    Ohnuma T; Roboz J; Shapiro ML; Holland JF
    Cancer Res; 1977 Jul; 37(7 Pt 1):2043-9. PubMed ID: 861933
    [No Abstract]   [Full Text] [Related]  

  • 3. Preferential incorporation of sangivamycin into ribonucleic acid in Sarcoma 180 cells in vitro.
    Ritch PS; Glazer RI
    Biochem Pharmacol; 1982 Jan; 31(2):259-61. PubMed ID: 7059368
    [No Abstract]   [Full Text] [Related]  

  • 4. Duration of inhibition of synthesis of DNA in tumors and host tissues after single doses of nitrosoureas.
    Wheeler GP; Alexander JA
    Cancer Res; 1974 Aug; 34(8):1957-64. PubMed ID: 4842249
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of tetrahydrohomofolate (NSC 89473) in mice.
    Mishra LC; Parmar AS; Mead JA
    Cancer Res; 1974 May; 34(5):964-7. PubMed ID: 4823905
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative pharmacokinetics of daunomycin and adriamycin in several animal species.
    Yesair DW; Schwartzbach E; Shuck D; Denine EP; Asbell MA
    Cancer Res; 1972 Jun; 32(6):1177-83. PubMed ID: 5030818
    [No Abstract]   [Full Text] [Related]  

  • 7. Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
    Glazer RI; Hartman KD
    Mol Pharmacol; 1981 Nov; 20(3):657-61. PubMed ID: 7329408
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction and metabolism of dihydrohomofolate in rhesus monkeys.
    Mishra LC; Parmar AS; Mead JA
    Cancer Res; 1974 Dec; 34(12):3187-91. PubMed ID: 4429948
    [No Abstract]   [Full Text] [Related]  

  • 9. [A study of the toxicity, pharmacokinetics and pharmacodynamics of the new antitumor antibiotic carminomycin].
    Goldberg LE; Filippos'iants ST; Kunrat IA; Stepanova ES; Shepelevtseva NG
    Antibiotiki; 1974 Jan; 19(1):57-62. PubMed ID: 4463841
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of antileukemic (L1210) treatment schedule on disposition of (minus)-emetine hydrochloride (NSC 33669) in normal and leukemic mice.
    Auletta AE; Gery AM; Mead JA
    Cancer Res; 1974 Jul; 34(7):1581-5. PubMed ID: 4833911
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of urethan with macromolecules in male and female newborn, adult, and tumor-bearing mice.
    Chavon BG; Bhide SV
    J Natl Cancer Inst; 1972 Oct; 49(4):1019-25. PubMed ID: 5084120
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparisons of radiocolloid distribution following administration by portal vein and peripheral vein injections.
    Ackerman NB
    J Nucl Med; 1967 May; 8(5):349. PubMed ID: 6032643
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--I. 6-[3H]-5-fluorouracil.
    Abrams DN; Knaus EE; Wiebe LI
    Int J Nucl Med Biol; 1979; 6(2):97-101. PubMed ID: 478772
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor uptake of radiolabeled pyrimidine bases and pyrimidine nucleosides in animal models--II. 6-[3H]-5-fluoro-2'-deoxyuridine.
    Abrams DN; Knaus EE; Lentle BC; Wiebe LI
    Int J Nucl Med Biol; 1979; 6(2):103-7. PubMed ID: 157998
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
    Meriwether WD; Bachur NR
    Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
    [No Abstract]   [Full Text] [Related]  

  • 16. The synthesis and metabolic fate of 14 C-viminol, a new analgesic, in the rat and the dog.
    Cameron BD; Chasseaud LF; Hardy G; Lewis JD; Saggers VH; Sword IP
    Arzneimittelforschung; 1973 May; 23(5):708-12. PubMed ID: 4197003
    [No Abstract]   [Full Text] [Related]  

  • 17. Tissue distribution and disposition of daunomycin (NCS-82151) in mice: fluorometric and isotopic methods.
    Bachur NR; Moore AL; Bernstein JG; Liu A
    Cancer Chemother Rep; 1970 Apr; 54(2):89-94. PubMed ID: 5527015
    [No Abstract]   [Full Text] [Related]  

  • 18. Physiologic disposition and metabolism of (3H) ecgonine (cocaine metabolite) in the rat.
    Misra AL; Vadlamani NL; Bloch R; Nayak PK; Mule SJ
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):55-63. PubMed ID: 4847905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Metabolism and anti-convulsive action of 2-[beta-pyridyl-(2")-ethenyl]-3-(2'-methylphenyl)-quinazolinone-(4) (B169)].
    Mori A; Mukawa J; Okusu H; Kobayashi K; Mizuno A
    No To Shinkei; 1969 Mar; 21(3):271-5. PubMed ID: 5819332
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro translational activity of messenger RNA following treatment of human colon carcinoma cells with sangivamycin.
    Glazer RI; Hartman KD
    Mol Pharmacol; 1983 Nov; 24(3):509-12. PubMed ID: 6633511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.